Literature DB >> 33746619

Understanding barriers and facilitators to HIV testing in Canada from 2009-2019: A systematic mixed studies review.

Claudie Laprise1, Clara Bolster-Foucault1.   

Abstract

BACKGROUND: HIV testing is a core pillar of Canada's approach to sexually transmitted and blood-borne infection (STBBI) prevention and treatment and is critical to achieving the first Joint United Nations Programme on HIV/AIDS (UNAIDS) 90-90-90 target. Despite progress toward this goal, many Canadians remain unaware of their status and testing varies across populations and jurisdictions. An understanding of drivers of HIV testing is essential to improve access to HIV testing and reach the undiagnosed.
OBJECTIVE: To examine current barriers and facilitators of HIV testing across key populations and jurisdictions in Canada.
METHODS: A systematic mixed studies review of peer-reviewed and grey literature was conducted identifying quantitative and qualitative studies of barriers and facilitators to HIV testing in Canada published from 2009 to 2019. Studies were screened for inclusion and identified barriers and facilitators were extracted. The quality of included studies was assessed and results were summarized.
RESULTS: Forty-three relevant studies were identified. Common barriers emerge across key populations and jurisdictions, including difficulties accessing testing services, fear and stigma surrounding HIV, low risk perception, insufficient patient confidentiality and lack of resources for testing. Innovative practices that could facilitate HIV testing were identified, such as new testing settings (dental care, pharmacies, mobile units, emergency departments), new modalities (oral testing, peer counselling) and personalized sex/gender and age-based interventions and approaches. Key populations also face unique sociocultural, structural and legislative barriers to HIV testing. Many studies identified the need to offer a broad range of testing options and integrate testing within routine healthcare practices.
CONCLUSION: Efforts to improve access to HIV testing should consider barriers and facilitators at the level of the individual, healthcare provider and policy and should focus on the accessibility, inclusivity, convenience and confidentiality of testing services. In addition, testing services must be adapted to the unique needs and contexts of key populations.

Entities:  

Keywords:  Canada; HIV; barriers; facilitators; key populations; mixed studies; screening; systematic review; testing

Year:  2021        PMID: 33746619      PMCID: PMC7968477          DOI: 10.14745/ccdr.v47i02a03

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


  51 in total

1.  Systematic mixed studies reviews: leveraging the literature to answer complex questions through the integration of quantitative and qualitative evidence.

Authors:  Helen Cerigo; Amélie Quesnel-Vallée
Journal:  Int J Public Health       Date:  2020-06-03       Impact factor: 3.380

Review 2.  Factors impacting HIV testing: a review--perspectives from Australia, Canada, and the UK.

Authors:  K Bolsewicz; A Vallely; J Debattista; A Whittaker; L Fitzgerald
Journal:  AIDS Care       Date:  2014-12-06

3.  HIV Testing Among a Representative Community Sample of Gay, Bisexual, and Other Men Who Have Sex with Men in Vancouver, Canada.

Authors:  Heather L Armstrong; Lu Wang; Julia Zhu; Nathan J Lachowsky; Kiffer G Card; Jason Wong; Jody Jollimore; Joshua Edward; Eric A Roth; Robert S Hogg; David M Moore
Journal:  AIDS Behav       Date:  2019-02

4.  Explaining the Presence of "Heterosexual" Female Clients of a Rapid HIV Testing Site Located in the Gay Village of Montreal, Quebec.

Authors:  Kim Engler; Kathleen Rollet; David Lessard; Réjean Thomas; Bertrand Lebouché
Journal:  J Prim Care Community Health       Date:  2016-01-20

5.  A Mixed-Methods Outcome Evaluation of a Mentorship Intervention for Canadian Nurses in HIV Care.

Authors:  Catherine A Worthington; Kelly K O'Brien; Judy Mill; Vera Caine; Patty Solomon; Jean Chaw-Kant
Journal:  J Assoc Nurses AIDS Care       Date:  2016-02-22       Impact factor: 1.354

6.  Individual and jurisdictional factors associated with voluntary HIV testing in Canada: Results of a national survey, 2011.

Authors:  Catherine A Worthington; Liviana M Calzavara; Samantha J White; Dan Allman; Mark W Tyndall
Journal:  Can J Public Health       Date:  2014-11-06

7.  Barriers to gender-equitable HIV testing: going beyond routine screening for pregnant women in Nova Scotia, Canada.

Authors:  Jacqueline C Gahagan; Janice L Fuller; E Michelle Proctor-Simms; Todd F Hatchette; Larry N Baxter
Journal:  Int J Equity Health       Date:  2011-05-11

8.  Nondisclosure prosecutions and population health outcomes: examining HIV testing, HIV diagnoses, and the attitudes of men who have sex with men following nondisclosure prosecution media releases in Ottawa, Canada.

Authors:  Patrick O'Byrne; Jacqueline Willmore; Alyssa Bryan; Dara S Friedman; Andrew Hendriks; Cynthia Horvath; Dominique Massenat; Christiane Bouchard; Robert S Remis; Vera Etches
Journal:  BMC Public Health       Date:  2013-02-01       Impact factor: 3.295

9.  Will an unsupervised self-testing strategy be feasible to operationalize in Canada? Results from a pilot study in students of a large canadian university.

Authors:  Nitika Pant Pai; Madhavi Bhargava; Lawrence Joseph; Jigyasa Sharma; Sabrina Pillay; Bhairavi Balram; Pierre-Paul Tellier
Journal:  AIDS Res Treat       Date:  2014-01-09

10.  Acceptability, predictors and attitudes of Canadian women in labour toward point-of-care HIV testing at a single labour and delivery unit.

Authors:  Salikah Iqbal; Leanne R De Souza; Mark H Yudin
Journal:  Can J Infect Dis Med Microbiol       Date:  2014-07       Impact factor: 2.471

View more
  1 in total

1.  Frameworks, measures, and interventions for HIV-related internalised stigma and stigma in healthcare and laws and policies: systematic review protocol.

Authors:  Susanne Hempel; Laura Ferguson; Maria Bolshakova; Sachi Yagyu; Ning Fu; Aneesa Motala; Sofia Gruskin
Journal:  BMJ Open       Date:  2021-12-09       Impact factor: 3.006

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.